Medisanté
Lionel Cavalliere serves as the Chief Operating Officer and VP of Business Development at Medisanté since August 2019, focusing on enhancing global healthcare efficiency through cellular IoT technologies for hospital-at-home solutions. Prior to this role, Lionel held various key positions at VMware from February 2007 to July 2019, including Director of Solutions and Portfolio Marketing for EMEA, where responsibility included spearheading product launches and marketing strategies across Europe. Additional leadership roles encompassed Director of Product Marketing and Senior Product Marketing Manager within VMware, as well as Product Manager at EMC Software and Pre-Sales Systems Engineer at LEGATO. Educational credentials include an Executive MBA from ESCP Business School, a specialized degree in Leading Digital Transformation & Innovation from INSEAD, and an engineering degree in Aeronautics and Software Programming from ISAE-SUPAERO, alongside a Master's degree in Software Development from Télécom Paris.
This person is not in any teams
This person is not in any offices
Medisanté
Medisanté is a Swiss innovator in medical IoT and is part of PariSanté Campus. It enables the hospital at home with global cellular IoT. This is the only way to keep the device experience seamless and secure at scale for all stakeholders involved in virtual care. Medisanté Hub (M+ Hub) is the 1st global medical IoT cloud infrastructure that abstracts in one cloud a broad range of devices provisioned by care teams and requiring no configuration by patients. By connecting and managing such devices “powered by Medisanté” - from Beurer e.g. and from other manufacturers - over a global private cellular network, M+ Hub redefines device interoperability globally for health IT teams and enables fleet management for biomedical engineers across country, vendor, and platform silos. As a medical device data system (MDDS), it delivers medical IoT data-as-a-Service (DaaS) to care teams in the 3rd party compliant platform of their choice and lets them scale remote patient monitoring (RPM) or decentralized clinical trials (DCT) with no compromise on security, privacy, or inclusion.